Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Fajgenbaum

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|August 24, 2022
Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal Mass. ReplyDavid C Fajgenbaum
Hematology. American Society of Hematology. Education Program|December 4, 2018
Novel insights and therapeutic approaches in idiopathic multicentric Castleman diseaseDavid C Fajgenbaum
Blood|November 30, 2018
Novel insights and therapeutic approaches in idiopathic multicentric Castleman diseaseDavid C Fajgenbaum
Advances in Experimental Medicine and Biology|August 8, 2024
The Cytokine Storm of Multicentric Castleman DiseaseDavid C Fajgenbaum
Current Opinion in Rheumatology|July 15, 2021
Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debatePuja Mehta, David C Fajgenbaum
Blood|February 28, 2020
Overview of Castleman diseaseAngela Dispenzieri, David C Fajgenbaum
Immunotherapy|December 5, 2015
Siltuximab: a targeted therapy for idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Razelle Kurzrock
Hematology/Oncology Clinics of North America|November 22, 2017
Castleman Disease PathogenesisDavid C Fajgenbaum, Dustin Shilling
Hematology. American Society of Hematology. Education Program|December 7, 2024
Identifying Castleman disease from non-clonal inflammatory causes of generalized lymphadenopathySally Nijim, David C Fajgenbaum
Clinical Advances in Hematology & Oncology : H&O|September 20, 2022
How we manage idiopathic multicentric Castleman diseaseJoshua D Brandstadter, David C Fajgenbaum
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|August 24, 2022
Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal Mass. ReplyDavid C Fajgenbaum
Hematology. American Society of Hematology. Education Program|December 4, 2018
Novel insights and therapeutic approaches in idiopathic multicentric Castleman diseaseDavid C Fajgenbaum
Blood|November 30, 2018
Novel insights and therapeutic approaches in idiopathic multicentric Castleman diseaseDavid C Fajgenbaum
Advances in Experimental Medicine and Biology|August 8, 2024
The Cytokine Storm of Multicentric Castleman DiseaseDavid C Fajgenbaum
Current Opinion in Rheumatology|July 15, 2021
Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debatePuja Mehta, David C Fajgenbaum
Blood|February 28, 2020
Overview of Castleman diseaseAngela Dispenzieri, David C Fajgenbaum
Immunotherapy|December 5, 2015
Siltuximab: a targeted therapy for idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Razelle Kurzrock
Hematology/Oncology Clinics of North America|November 22, 2017
Castleman Disease PathogenesisDavid C Fajgenbaum, Dustin Shilling
Hematology. American Society of Hematology. Education Program|December 7, 2024
Identifying Castleman disease from non-clonal inflammatory causes of generalized lymphadenopathySally Nijim, David C Fajgenbaum
Clinical Advances in Hematology & Oncology : H&O|September 20, 2022
How we manage idiopathic multicentric Castleman diseaseJoshua D Brandstadter, David C Fajgenbaum
Pageof 12